Monday, August 18, 2014

[ssf] Dr. Jergen's Device







































______________________________________________________________________________
To: HRJergen@[redacted].[redacted]
From: [Redacted]
CC: [Redacted]

Dear Dr. Jergen,

We are patent attorneys retained by the Corporation for the purposes of securing protection on any intellectual property developed by employees and ensuring that such intellectual property is properly assigned to the Corporation and recorded as a corporate asset.

We were recently asked by Chief Counsel [Redacted] to evaluate the likelihood of receiving patent protection on your "entity retention device", cover sheet above.  

We have been made aware of the circumstances surrounding the development and intended use(s) of such a device and have evaluated it with that information in hand.

Let us be the first to say that we appreciate that the device development timeline was necessarily shortened due to [Redacted], and the design and implementation decisions made were under truly harrowing circumstances. 

We also appreciate that the end result was highly successful in assisting in the resolution of  [Redacted]. However, we do not believe your invention will pass muster at the Patent Office for number reasons.

Principally, the "mechanisms of operation" of your invention are not explicitly described nor fully explicable given generally agreed upon natural and scientific laws. 

Furthermore, certain subsystems (denoted in the various annotated scripts ) of your invention operate using substances that are not readily available, or have attendant ethical challenges that make duplication or acquisition by persons outside the Company, unlikely.  

It should be noted that the Patent Office could evaluate such extraordinary claims, if demonstrable evidence were provided. 

Technically, we are in possession of such evidence, in the form of video footage from the most recent event which highlights the use of the device in sequestering and transporting [Redacted]. However, knowledge of [Redacted] is a closely guarded corporate trade secret. We are under professional, ethical and contractual obligations to not to disclose the nature of these circumstances to the public.   As you were well aware, the consequences for failing to adhere to these edicts are significant

As such, we would only have your unverified statements in support of a patent. Therefore, we have advised the General Counsel to not proceed and to close this file. 


Please do not view our decisions as minimizing the effort you put towards resolving [Redacted]. We look forward to working with you and your team in the future on the [Redacted] project, which we believe to be quite lucrative and impressive technological development. 


 Your Truly, 

No comments:

Post a Comment